Contact Us: 1-518-583-0095 
We’re Hiring… Join Our Team!
With skin cancer rates on the rise and the first new sunscreen ingredient approved by the FDA in twenty years coming to market in August, skin cancer prevention is a hot topic this summer.
Learn about the latest skin cancer facts and statistics and the latest advancements in research.
Continue readingDr. Paul Oberstein, a pancreatic cancer expert and member of the Academic GI Cancer Consortium (AGICC), discusses new data showing positive results from a Phase 3 pancreatic cancer study of an experimental drug by Revolution Medicines.
Continue reading
Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), discusses his diagnosis in 2022 of Stage IV EGFR-positive non-small cell lung cancer in an article published in ASTRO (American Society for Radiation Oncology) News.
Dr. Camidge also explores the cancer patient experience from his unique perspective as a treatment provider, researcher and patient in a Cracking Cancer podcast episode and a video interview with The Patient Story.
Continue reading
We are excited to attend the 2026 ASCO Gastrointestinal Cancers Symposium, held in San Francisco on January 8-10, 2026. Our semi-annual Investigator’s Meeting of the Academic GI Cancer Consortium (AGICC) will be held on Thursday, January 8th, bringing together AGICC researchers to discuss new developments, collaboration opportunities and potential studies for 2026.
Continue reading
As the second leading cause of cancer in both men and women in the U.S., small cell and non-small cell lung cancer affects thousands of people each year. In recent years, advances in diagnosis and treatment have improved drastically, enhancing quality of life and increasing the length of life for patients.
Continue reading
Breast cancer remains a significant health concern worldwide, affecting millions of people each year.
Breast cancer is the most commonly diagnosed cancer among women in the U.S. Approximately 32% of all newly diagnosed cancers in women are breast cancer.
As we continue to advance medical research and treatment, it is crucial to stay informed about the latest statistics and trends.
Continue reading
Breast cancer continues to be a major health challenge, but advancements in research, early detection, and treatment offer hope for better outcomes. Breast cancer research has remained a priority in oncology; millions of dollars are invested in breast cancer research annually, ensuring that innovation and progress continue. As a result of this significant investment, breast cancer researchers are exploring new and exciting approaches to research and investigating promising solutions that could be applied to other areas of oncology.
Continue readingSkin cancer is the most common cancer worldwide, affecting 1 in 5 people in the United States by age 70. In the U.S., more people are diagnosed with skin cancer each year than all other cancers combined.
Discover some of the latest advancements in skin cancer prevention, diagnosis, and treatment.
Continue reading
The Oncology Consortia of Criterium held their annual Investigator Meetings at the 2025 ASCO Annual Meeting. These gatherings foster an invaluable collaboration and innovation among leading experts in the field, across a wide range of institutions – driving forward our shared mission to advance cancer research and improve patient outcomes.
Continue reading
Learn about recent advances in cancer research across many areas, including myeloma, lung cancer, and pediatric cancers.
Continue reading